Artificial Intelligence Model for Growth Prediction of Ovarian Cancer Organoids

This study uses artificial intelligence to predict how cancer cells from ovarian cancer patients will grow in lab-grown mini-tumors called organoids. The goal is to use AI to help predict a patient's response to treatment, potentially improving how doctors choose therapies. **You may be eligible if...** - You have a confirmed diagnosis of epithelial ovarian cancer (the most common type) - You have had a biopsy or procedure to collect tumor tissue or fluid containing cancer cells - You are willing to participate and have signed the informed consent **You may NOT be eligible if...** - Your ovarian cancer is a non-epithelial type - There is not enough tumor tissue or fluid available to grow the mini-tumors needed for the study Talk to your doctor to see if this trial is right for you.